ProtoKinetix, Incorporated
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PKTX research report →
About the company
ProtoKinetix, Incorporated is a biotechnology firm engaged in research and development, specializing in the scientific and medical investigation of glycoproteins known as anti-freeze glycoproteins (AFGPs) and anti-aging glycoproteins (AAGPs). These AFGPs are particularly relevant for their commercial potential within the healthcare sector, with a key area of their development involving utilizing AAGPs for the treatment of dry-eye conditions. Their research efforts are bolstered by a collaborative agreement with the University of British Columbia.
- CEO
- Michael Richard Guzzetta
- IPO
- 2002
- Employees
- 5
- HQ
- Marietta, OH, US
Price Chart
- Market Cap
- $2.04M
- P/E
- -13.00
- P/S
- 0.00
- P/B
- 8.09
- EV/EBITDA
- -8.64
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -86.22%
- ROIC
- -104.22%
- Revenue
- $0 · 0.00%
- Net Income
- $-364,000 · 12.29%
- EPS
- $-0.00 · 90.00%
- Op Income
- $-311,000
- FCF YoY
- 48.74%
- 52W High
- $0.01
- 52W Low
- $0.00
- 50D MA
- $0.01
- 200D MA
- $0.01
- Beta
- 0.75
- Avg Volume
- 33.22K
Get TickerSpark's AI analysis on PKTX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 17, 26 | Jones Michael Winston | other | 0 |
| Sep 26, 24 | SMITH CLARENCE EDWARD | buy | 2,000,000 |
| Jun 14, 24 | SMITH CLARENCE EDWARD | buy | 3,100,000 |
| Jun 13, 24 | SMITH CLARENCE EDWARD | buy | 3,400,000 |
| Mar 29, 24 | SMITH CLARENCE EDWARD | buy | 2,500,000 |
| Mar 20, 24 | SMITH CLARENCE EDWARD | buy | 666,667 |
| Dec 26, 23 | SMITH CLARENCE EDWARD | buy | 7,333,334 |
| Oct 26, 23 | Guzzetta Michael Richard | buy | 20,000 |
| Aug 29, 23 | SMITH CLARENCE EDWARD | buy | 1,500,000 |
| Jun 15, 23 | SMITH CLARENCE EDWARD | buy | 2,000,000 |
Our PKTX coverage
Recent articles, reports, and earnings notes.
No research on PKTX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate PKTX report →Similar companies
Peers in the same neighborhood.